September 18, 2012
According to researchers in Madrid, Spain, intestinal bacteria in blood (bacterial translocation) is associated with more severe liver disease in persons with HIV/hepatitis C virus coinfection. To determine the association between the severity of bacterial translocation and the extent and pace of liver disease, the researchers studied 255 co-infected individuals who had undergone a liver biopsy between 2000 and 2007. One hundred blood donors who were not infected with HIV/hepatitis C were used as controls. All participants were tested for DNA of intestinal bacteria in their blood, and coinfected individuals were assessed for the stage and pace of liver fibrosis. People with more advanced fibrosis and faster progression of liver disease had higher levels of intestinal bacteria in their blood than those without the markers of liver disease. The authors concluded that bacterial translocation was associated with severe liver disease among HIV-infected patients with chronic hepatitis C. The study was reported online in the Journal of Acquired Immune Deficiency Syndromes.
[PNU Editor's Note: The study, "Bacterial DNA Translocation and Liver Disease Severity Among HIV-Infected Patients With Chronic Hepatitis C," was published ahead of the print version of the Journal of Acquired Immune Deficiency Syndromes (DOI:10.1097/QAD.0b013e318263q109, 2012)].
09.13.2012; Michael Carter
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals|
|This Week in HIV Research: Another Person Possibly Cured of HIV; and Long-Acting Rilpivirine Suppresses HIV in Rectal Tissue|
|This Week in HIV Research: HIV-Related Inflammation May Be Irreversible; and Genetically Engineered T-Cells Resist HIV|
|How Close Are We to a Cure for HIV? A Q&A With HIV Cure Scientific Superstars|
|Dolutegravir and the Central Nervous System: A Top HIV Clinical Development of 2016|